Skip to content
PulseMS
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedPeer review unconfirmed

Human Subjects Study on CD4+ T Cells Transformation

A study involving three healthy donors and three multiple sclerosis patients examined the transformation of CD4+ T cells into regulatory T cells (Tregs). The transformed Tregs (tTregs) showed increased levels of the full-length FoxP3 splice variant and enhanced proliferative and suppressive activities compared to expanded Tregs (eTregs).

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

This research highlights differences in Treg generation methods, with tTregs showing potential advantages in terms of FoxP3 variant expression and functional capabilities. However, these findings are laboratory-based and do not address clinical outcomes.

What this does not prove

The study does not establish clinical outcomes as it focuses solely on laboratory findings regarding Treg transformation and expansion.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Not reported
Participants / samples
6 · Three healthy donors and three patients with multiple sclerosis
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
Not reported
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified

Original sources

Supporting passages (8)
subjectsHuman
sample sizeIn this study, we used cells obtained from three healthy donors and three patients with multiple sclerosis to compared the levels of FoxP3 splice variants in Tregs during their ex vivo expansion (expanded Tregs, eTregs) and Tregs generated by transformation of CD4+ T cells (transformed Tregs, tTregs).
sample size basisIn this study, we used cells obtained from three healthy donors and three patients with multiple sclerosis to compared the levels of FoxP3 splice variants in Tregs during their ex vivo expansion (expanded Tregs, eTregs) and Tregs generated by transformation of CD4+ T cells (transformed Tregs, tTregs).
interventionTitle: Induction of the Full-Length FoxP3 Splice Variant during ex vivo Transformation of Human CD4+ T Lymphocytes into Regulatory T Cells.
comparatorIn contrast, ex vivo expansion of eTregs did not alter the proportions of FoxP3 splice variants; these cells proliferated less actively and exhibited lower suppressive activity than tTregs.
primary endpointOur findings demonstrate that transformation of CD4+ T cells into Tregs is accompanied by an increase in the proportion of the full-length FoxP3 splice variant.
findingsOur findings demonstrate that transformation of CD4+ T cells into Tregs is accompanied by an increase in the proportion of the full-length FoxP3 splice variant.
limitationsTitle: Induction of the Full-Length FoxP3 Splice Variant during ex vivo Transformation of Human CD4+ T Lymphocytes into Regulatory T Cells.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.